Lastly, our study holds crucial implications for therapeutic approaches with JAK/STAT inhibitors currently under study in addition to elucidating the mechanisms by which STAT activation is regulated in SLE. This evidence concerns the gene SOAT1 and systemic lupus erythematosus.